Friedrich HILLEBRAND

, PhD

Investor, Hil-Invent

Friedrich Hillebrand, PhD, has more than 40 years of deep experience in a broad variety of aspects in the pharmaceutical industry such as Research and Development, Manufacturing and Quality, Business Development, Marketing and Sales. He held the position as CEO of EBEWE Pharma and is now president of EVER Pharma. Friedrichwas involved in several M&A transactions and led the billion dollar sale of the EBEWE Oncology business to Novartis. He holds several board positions and received his PhD in chemistry from the Technical University of Vienna.